WE examined in the present study the effects of the centrally administered prepro-thyrotropin-releasing-hormone 178-199 (prepro-TRH 178- 199) on cerebral ischemia induced by ligation of the middle cerebral artery (MCA) in adult Sprague-Dawley rats. Animals were intracerebrally injected with prepro-TRH 178-199 (6 μg/kg or 200 μg/kg) or saline 1-2h before ligation of MCA. Ischemic animals that received prepro-TRH 178199, regardless of dosage, displayed some amelioration (20%) of motor asymmetry associated with MCA ligation, while ischemic animals that received saline continued to exhibit significant asymmetrical behaviors. Interestingly, triphenyltetrazolium chloride staining (a marker for tissue metabolic activity) revealed that four of five ischemic animals that received 200 μg/kg prepro-TRH 178-199 showed a marked reduction (90-100%) in the infarction of the frontal cortex, although the posterior sections of the cortex remained infarcted. In contrast, ischemic animals that received 6 μg/kg prepro-TRH 178-199 demonstrated infarction that did not differ in size and extent from those that received saline. Post hoc examination revealed that ischemic animals treated with 200 μg/kg prepro-TRH 178-199 had significantly lower corticosterone (CORT) levels (115 ± 23 ng/ml) than ischemic animals treated with 6 μg/kg prepro-TRH 178-199 or saline (288 ± 51 ng/ml). The present observation provides the first evidence that prepro- TRH 178-199 can promote neuroprotection against cerebral ischemia.
- Corticotrophin release-inhibiting factor
- Locomotor activity
ASJC Scopus subject areas